503B
Licensed U.S. compounding pharmacies
Medications filled by licensed U.S. pharmacies.
Yucca Health is a telehealth clinic offering personalized GLP-1 weight-loss treatment (semaglutide/tirzepatide) starting at $146/month with 24/7 support.
Pricing note: Compounded semaglutide promotional 6-month plan at $146/mo. Compounded tirzepatide $258/mo per the public tirzepatide and explore-treatments pages. Brand-name GLP-1 cash pricing not published.
Yucca Health provides an online GLP-1 program and ancillary services (NAD+, peptides). It connects patients with U.S. providers for compounded semaglutide or tirzepatide therapy. New patients can enroll in a 6-month semaglutide plan at $146/mo (with autoship and dedicated support). The platform promises provider review within 24 hours and home delivery via 2-day shipping. Yucca emphasizes patient experience (24/7 staff, free consultation) and flexible policies. They allow cancel anytime (not charged unless prescribed). Trustpilot shows a 4.6/5 rating (1,047 reviews).
Uses licensed U.S. pharmacies for compounding medications.
Medications filled by licensed U.S. pharmacies.
We don’t republish individual user quotes — too easy to misattribute, too easy to lose context. Below are the aggregate ratings from public review platforms with links to read actual reviews at the source. Counts are rounded down to a confident floor (e.g. 12,788 → 12,000+).
Click any source above to read the actual reviews. Ratings reflect the platform’s own reported aggregate at last verification (May 6, 2026).
Flexible cancel-anytime policy; only charged if prescription is approved.
No refunds once medications ship; refunds only for billing errors or if provider denies treatment.
Licensed U.S. doctors review cases (typically within 24h) and support patients throughout treatment.
Pricing and policies above were verified May 6, 2026. Always re-verify on the provider’s site at the moment of purchase.
Email corrections@epioneum.com with the field, the number we have, the number you believe is correct, and a primary or secondary source. We respond within 14 days.